Literature DB >> 16683385

Disclosure of cancer diagnosis to patients and their relatives in Turkey: views of accompanying persons and influential factors in reaching those views.

Berna Oksüzoğlu1, Hüseyin Abali, Meral Bakar, Nuriye Yildirim, Nurullah Zengin.   

Abstract

AIMS AND
BACKGROUND: In Turkey, it is a common belief that most family members of patients with cancer would not want them to be informed of a diagnosis of cancer. Our aim was to evaluate the attitudes and opinions of people accompanying cancer patients, regarding cancer diagnosis disclosure.
METHODS: In a cross-sectional study 270 caregivers accompanying cancer patients during outpatient chemotherapy sessions were asked to fill in a questionnaire to determine their opinions regarding whether the diagnosis of cancer should be disclosed to the patients and their relatives or not. Timing of telling the diagnosis and from whom it should be learned were queried as well. Possible influential factors for the answers were analyzed with the chi-square test.
RESULTS: Of the 270 accompanying persons, 130 (48.2%) said that the patients should be informed of the diagnosis, whereas a greater number (236, 87.4%) believed that the patient's relatives should be informed. Being younger than 40 years old (P = 0.0005), being unmarried (P = 0.002), having a higher educational status (P = 0.0001) and having passed less than four months since the diagnosis (P = 0.005) positively affected opinions regarding telling the truth to the patient. Higher education (P = 0.012) and high monthly income (P = 0.002) positively affected opinions regarding disclosing a diagnosis of cancer to the patient's relatives.
CONCLUSION: As a result, in a survey of caregivers' points of view, more than half of the accompanying persons did not agree with disclosing a cancer diagnosis to patients, whereas the majority agreed with disclosing it to the relatives, and educational level seemed to be the major influential factor.

Entities:  

Mesh:

Year:  2006        PMID: 16683385     DOI: 10.1177/030089160609200110

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  7 in total

1.  Students meeting with caregivers of cancer patient: results of an experience-based learning project.

Authors:  Beste M Atasoy; Ozlem Sarikaya; M Kemal Kuscu; Merve Yondem; Elif Buyukkara; E Gokcen Eken; Figen Kahyaoglu
Journal:  J Cancer Educ       Date:  2012-12       Impact factor: 2.037

Review 2.  Truth Telling in the Setting of Cultural Differences and Incurable Pediatric Illness: A Review.

Authors:  Abby R Rosenberg; Helene Starks; Yoram Unguru; Chris Feudtner; Douglas Diekema
Journal:  JAMA Pediatr       Date:  2017-11-01       Impact factor: 16.193

3.  Attitudes Toward Cancer and Cancer Patients in an Urban Iranian Population.

Authors:  Shervin Badihian; Eun-Kyung Choi; Im-Ryung Kim; Aidin Parnia; Navid Manouchehri; Negin Badihian; Jila M Tanha; Eliseo Guallar; Juhee Cho
Journal:  Oncologist       Date:  2017-05-30

4.  Psychological impact of revealing a diagnosis of lung cancer to patients in China.

Authors:  Huimin Qian; Lili Hou
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

5.  'Palliative care': a contradiction in terms? A qualitative study of cancer patients with a Turkish or Moroccan background, their relatives and care providers.

Authors:  Fuusje M de Graaff; Anneke L Francke; Maria Etc van den Muijsenbergh; Sjaak van der Geest
Journal:  BMC Palliat Care       Date:  2010-09-10       Impact factor: 3.234

6.  Perspectives on care and communication involving incurably ill Turkish and Moroccan patients, relatives and professionals: a systematic literature review.

Authors:  Fuusje M de Graaff; Patriek Mistiaen; Walter Ljm Devillé; Anneke L Francke
Journal:  BMC Palliat Care       Date:  2012-09-18       Impact factor: 3.234

7.  Information to cancer patients: a questionnaire survey in three different geographical areas in Italy.

Authors:  R Bracci; E Zanon; R Cellerino; R Gesuita; F Puglisi; G Aprile; V Barbieri; D Misuraca; S Venuta; F Carle; A Piga
Journal:  Support Care Cancer       Date:  2008-01-26       Impact factor: 3.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.